anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

List

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,471
Current window 71,671-71,700
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all
18 30 60

Component

71,671-71,700 of 110,471

filter-aware
321
The slide uses a Q&A transcript format to expose flaws in the clinical trial design regarding pill size.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
322
The slide uses a Q&A transcript format to undermine the company's product value proposition.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
324
The slide uses a Q&A format to highlight the failure of the trial's blinding protocol.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
355
The slide uses a Q&A format to build a case for market substitution risk.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
364
The slide uses verbatim quotes from a consultation call to highlight a discrepancy between the company's risk management (handouts) and the physician's expectations of transient vs. permanent side effects.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
374
The slide uses a Q&A transcript format to expose potential flaws in clinical trial methodology and physician sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
377
The slide uses a Q&A format to expose a gap in the company's support infrastructure.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
382
The slide uses a Q&A transcript format to highlight the physician's frustration and lack of guidance from the manufacturer.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
392
The slide uses direct quotes and Q&A excerpts to build a case against the safety of the drug Vykat in the context of PWS treatment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
396
The slide uses direct quotes from a pediatric endocrinologist to undermine the company's commercial narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
412
The slide uses a Q&A transcript format to validate the claim of trial unblinding.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
01
Slide 1
The slide uses aggressive, accusatory language typical of short-seller research reports.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
13
The slide uses heavy anecdotal evidence and expert quotes to build a case against the product's viability.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment1 hit
14
The slide uses anecdotal evidence and expert quotes to build a case against the product's viability.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment1 hit
15
The slide uses expert testimony and industry comparisons to frame Lasertec's product as inferior to ASML's technology.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Aha Moment1 hit
17
The slide uses investigative journalism techniques to build a case of corporate deception.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
23
The slide relies on primary source interviews with an Isteq engineer to discredit Lasertec's technical capabilities.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
31
The slide uses bulleted expert testimony to build a case against the reliability and adoption success of Lasertec's ACTIS tools at TSMC.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
36
Contains specific anecdotal evidence from industry executives at Global Foundries and Marvell.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
37
The slide uses direct quotes from customer interviews to build a narrative of corporate malfeasance and operational struggle.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
49
The slide uses expert quotes to build a narrative of competitive displacement and regulatory pressure.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
09
TransMedics (TMDX)TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
10
TransMedics (TMDX)TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
12
The slide uses a 'Spy The Lie' framework to interpret CEO responses as deceptive.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
16
The slide uses a 'wink-wink' narrative to frame the company's own marketing as evidence of a non-clinical value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
29
The slide uses a Q&A format to highlight specific allegations from an industry executive regarding OIG, DOJ, and IRS involvement.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
32
The slide uses a Q&A transcript format to build a narrative about an ongoing investigative report.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
33
The slide uses a Q&A format to highlight potential financial incentives and investigative scrutiny regarding TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
37
The slide uses a Q&A format and direct quotes to build a narrative of a toxic, insular culture.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
38
This is a short-seller research note attempting to cast doubt on management integrity via association.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit